See the published version of this preprint at Systematic Reviews.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Protocol
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: The COVID-19 pandemic is creating severe issues for healthcare and broad social structures, exposing societal vulnerabilities. Among the populations affected by COVID-19 are people engaged in substance use, such as people who smoke, vape (e-cigarette use), use opioids, cannabis, alcohol, psychoactive prescription drugs, or have a substance use disorder (SUD).
Monitoring substance use and SUD during the pandemic is essential, as people who engage in substance use or present with SUD are at greater risk for COVID-19, and the economic and social changes resulting from the pandemic may aggravate SUD. There have been several reviews focused on COVID-19 in
relation to substance use and SUD. Reviews generally did not consider on a large range of substance use variants or SUDs. We plan a scoping review that seeks to fill gaps in our current understanding of substance use and SUD, in the
COVID-19 era.
Methods: A scoping review focused on substance use and SUD, in relation to COVID-19, will be conducted. Databases such as MEDLINE, Embase, PsycINFO, Global Health, and Sociological Abstracts will be searched to capture current literature and preprints. Study selection will conform to Joanna Briggs Institute Reviewers’ Manual 2015 Methodology for JBI Scoping Reviews.
Results: N/A
Conclusions: Original research is urgently needed to mitigate the risks of COVID-19 on substance use and SUD. The planned scoping review will help address this gap.
Systematic Review registrations: N/A
Keywords
COVID-19, substance use disorder, substance use, SUD
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Systematic Reviews.
No community comments so far
Editorial decision: Accept
On 26 Jan, 2021
Editor assigned
On 25 Jan, 2021
Submission checks complete
On 25 Jan, 2021
Editor invited
On 25 Jan, 2021
Version 1
Posted 04 Sep, 2020
No comments provided
Reviewer #1 agreed
On 08 Jan, 2021
Editor assigned
On 05 Jan, 2021
Reviewers invited
Invitations sent on 05 Jan, 2021
Editor invited
On 05 Jan, 2021
Submission checks complete
On 03 Sep, 2020
First submitted
On 02 Sep, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
See the published version of this preprint at Systematic Reviews.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Protocol
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Systematic Reviews.
No community comments so far
Editorial decision: Accept
On 26 Jan, 2021
Editor assigned
On 25 Jan, 2021
Submission checks complete
On 25 Jan, 2021
Editor invited
On 25 Jan, 2021
Version 1
Posted 04 Sep, 2020
No comments provided
Reviewer #1 agreed
On 08 Jan, 2021
Editor assigned
On 05 Jan, 2021
Reviewers invited
Invitations sent on 05 Jan, 2021
Editor invited
On 05 Jan, 2021
Submission checks complete
On 03 Sep, 2020
First submitted
On 02 Sep, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Systematic Reviews.
Background: The COVID-19 pandemic is creating severe issues for healthcare and broad social structures, exposing societal vulnerabilities. Among the populations affected by COVID-19 are people engaged in substance use, such as people who smoke, vape (e-cigarette use), use opioids, cannabis, alcohol, psychoactive prescription drugs, or have a substance use disorder (SUD).
Monitoring substance use and SUD during the pandemic is essential, as people who engage in substance use or present with SUD are at greater risk for COVID-19, and the economic and social changes resulting from the pandemic may aggravate SUD. There have been several reviews focused on COVID-19 in
relation to substance use and SUD. Reviews generally did not consider on a large range of substance use variants or SUDs. We plan a scoping review that seeks to fill gaps in our current understanding of substance use and SUD, in the
COVID-19 era.
Methods: A scoping review focused on substance use and SUD, in relation to COVID-19, will be conducted. Databases such as MEDLINE, Embase, PsycINFO, Global Health, and Sociological Abstracts will be searched to capture current literature and preprints. Study selection will conform to Joanna Briggs Institute Reviewers’ Manual 2015 Methodology for JBI Scoping Reviews.
Results: N/A
Conclusions: Original research is urgently needed to mitigate the risks of COVID-19 on substance use and SUD. The planned scoping review will help address this gap.
Systematic Review registrations: N/A
This is a list of supplementary files associated with this preprint. Click to download.
Loading...